ATE488253T1 - Verfahren zum nachweis eines fibringerinnsels - Google Patents

Verfahren zum nachweis eines fibringerinnsels

Info

Publication number
ATE488253T1
ATE488253T1 AT98934690T AT98934690T ATE488253T1 AT E488253 T1 ATE488253 T1 AT E488253T1 AT 98934690 T AT98934690 T AT 98934690T AT 98934690 T AT98934690 T AT 98934690T AT E488253 T1 ATE488253 T1 AT E488253T1
Authority
AT
Austria
Prior art keywords
detecting
source
particles
fibring
clot
Prior art date
Application number
AT98934690T
Other languages
English (en)
Inventor
Chenicheri Nair
Elena Shats
William Burch
Rodney Browitt
Timothy Senden
Original Assignee
Univ Australian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Australian filed Critical Univ Australian
Application granted granted Critical
Publication of ATE488253T1 publication Critical patent/ATE488253T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • A61K51/1251—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles micro- or nanospheres, micro- or nanobeads, micro- or nanocapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nanotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
AT98934690T 1997-07-24 1998-07-23 Verfahren zum nachweis eines fibringerinnsels ATE488253T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/AU1997/000467 WO1999004826A1 (en) 1997-07-24 1997-07-24 Method for detection of fibrin clots
PCT/AU1998/000582 WO1999004827A1 (en) 1997-07-24 1998-07-23 Method for detection of fibrin clots

Publications (1)

Publication Number Publication Date
ATE488253T1 true ATE488253T1 (de) 2010-12-15

Family

ID=3764343

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98934690T ATE488253T1 (de) 1997-07-24 1998-07-23 Verfahren zum nachweis eines fibringerinnsels

Country Status (8)

Country Link
US (1) US6977068B1 (de)
EP (1) EP1027080B1 (de)
JP (1) JP3943330B2 (de)
AT (1) ATE488253T1 (de)
AU (2) AU3532197A (de)
CA (1) CA2297399C (de)
DE (1) DE69842003D1 (de)
WO (2) WO1999004826A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999004826A1 (en) * 1997-07-24 1999-02-04 The Australian National University Method for detection of fibrin clots
WO2000078362A2 (de) * 1999-06-22 2000-12-28 Aventis Research & Technologies Gmbh & Co. Kg Stabile radioaktiv markierte nanopartikel, verfahren zur herstellung und ihrer verwendung
JP2003535063A (ja) * 2000-06-01 2003-11-25 ザ・ボード・オブ・リージェンツ・フォー・オクラホマ・ステート・ユニバーシティー 放射線医薬としてのナノ粒子のバイオコンジュゲート
EP1877105B1 (de) 2005-04-29 2013-08-14 The Australian National University Verfahren zur bildung einer injizierbaren radioaktiven zusammensetzung aus einer in kohlenstoff eingeschlossenen radioaktiven partikulären substanz
AU2006243805B2 (en) * 2005-04-29 2012-02-02 The Australian National University A method of forming an injectable radioactive composition of a carbon encapsulated radioactive particulate
AU2006200755B2 (en) * 2005-07-11 2011-02-10 Cyclomedica Australia Pty Limited Improved process for the production of a radioactive aerosol
KR20100135312A (ko) * 2008-04-24 2010-12-24 디 오스트레일리언 내셔널 유니버시티 합성 중합체의 방사성 표지화 방법
CA2721836C (en) 2008-04-24 2017-04-11 The Australian National University Methods for radiolabelling macromolecules
DE102009015792A1 (de) * 2009-03-23 2010-09-30 Technische Universität Dresden Mittel für die Diagnose der Lungenfunktion mittels Positronen-Emissions-Tomographie
GB0922497D0 (en) * 2009-12-23 2010-02-03 Hammersmith Imanet Ltd Preparation and use of 68GA labelled particles
JP2014501730A (ja) 2010-12-01 2014-01-23 ジ オーストラリアン ナショナル ユニバーシティ ヒストン阻害
JP2014521462A (ja) 2011-08-05 2014-08-28 シルク・ロード・メディカル・インコーポレイテッド 急性虚血性脳卒中を治療するための方法及びシステム
US10779855B2 (en) 2011-08-05 2020-09-22 Route 92 Medical, Inc. Methods and systems for treatment of acute ischemic stroke
US9265512B2 (en) 2013-12-23 2016-02-23 Silk Road Medical, Inc. Transcarotid neurovascular catheter
US10426497B2 (en) 2015-07-24 2019-10-01 Route 92 Medical, Inc. Anchoring delivery system and methods
EP4674460A3 (de) 2015-02-04 2026-03-25 Route 92 Medical, Inc. Schnelles aspirationsthrombektomiesystem
US11065019B1 (en) 2015-02-04 2021-07-20 Route 92 Medical, Inc. Aspiration catheter systems and methods of use
US10716915B2 (en) 2015-11-23 2020-07-21 Mivi Neuroscience, Inc. Catheter systems for applying effective suction in remote vessels and thrombectomy procedures facilitated by catheter systems
CN113368367B (zh) 2016-02-24 2024-03-29 禾木（中国）生物工程有限公司 柔性增强的神经血管导管
CN110381855B (zh) 2017-01-06 2023-07-04 因赛普特有限责任公司 用于动脉瘤治疗装置的抗血栓涂层
AU2018208460B2 (en) 2017-01-10 2023-03-16 Route 92 Medical, Inc. Aspiration catheter systems and methods of use
CN114916978B (zh) 2017-01-20 2025-02-25 92号医疗公司 单操作者颅内医疗装置输送系统和使用方法
US11395665B2 (en) 2018-05-01 2022-07-26 Incept, Llc Devices and methods for removing obstructive material, from an intravascular site
JP2021522885A (ja) 2018-05-01 2021-09-02 インセプト・リミテッド・ライアビリティ・カンパニーＩｎｃｅｐｔ，Ｌｌｃ 血管内部位から閉塞性物質を除去する装置および方法
CN112423824B (zh) 2018-05-17 2023-02-21 92号医疗公司 抽吸导管系统和使用方法
US11471582B2 (en) 2018-07-06 2022-10-18 Incept, Llc Vacuum transfer tool for extendable catheter
WO2020010310A1 (en) 2018-07-06 2020-01-09 Imperative Care, Inc. Sealed neurovascular extendable catheter
US11766539B2 (en) 2019-03-29 2023-09-26 Incept, Llc Enhanced flexibility neurovascular catheter
US11134859B2 (en) 2019-10-15 2021-10-05 Imperative Care, Inc. Systems and methods for multivariate stroke detection
JP2023507553A (ja) 2019-12-18 2023-02-24 インパラティブ、ケア、インク． 静脈血栓塞栓症を治療するための方法及びシステム
US11638637B2 (en) 2019-12-18 2023-05-02 Imperative Care, Inc. Method of removing embolic material with thrombus engagement tool
US11439799B2 (en) 2019-12-18 2022-09-13 Imperative Care, Inc. Split dilator aspiration system
EP4117762A4 (de) 2020-03-10 2024-05-08 Imperative Care, Inc. Neurovaskulärer katheter mit erhöhter flexibilität
US11207497B1 (en) 2020-08-11 2021-12-28 Imperative Care, Inc. Catheter with enhanced tensile strength
EP4225167A4 (de) 2020-10-09 2024-10-09 Route 92 Medical, Inc. Aspirationskathetersysteme und verfahren zur verwendung
US20230048388A1 (en) 2021-08-12 2023-02-16 Imperative Care, Inc. Robotically driven interventional device
USD1077996S1 (en) 2021-10-18 2025-06-03 Imperative Care, Inc. Inline fluid filter

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1243784A (en) * 1984-10-04 1988-10-25 William M. Burch Radionuclide metallic vapour
US5217705A (en) * 1987-09-25 1993-06-08 Neorx Corporation Method of diagnosing blood clots using fibrin-binding proteins
US5330768A (en) * 1991-07-05 1994-07-19 Massachusetts Institute Of Technology Controlled drug delivery using polymer/pluronic blends
US5248498A (en) * 1991-08-19 1993-09-28 Mallinckrodt Medical, Inc. Fullerene compositions for magnetic resonance spectroscopy and imaging
GB9203037D0 (en) * 1992-02-11 1992-03-25 Salutar Inc Contrast agents
JPH08502752A (ja) * 1992-10-27 1996-03-26 メルク エンド カンパニー インコーポレーテッド 抗炎症剤及び抗変性剤としての新規の置換アゼチジノン
AU686861B2 (en) * 1994-09-21 1998-02-12 Allrad No. 28 Pty Ltd A precipitator
DE19506188C2 (de) * 1995-02-22 2003-03-06 Miladin Lazarov Implantat und dessen Verwendung
US5640705A (en) * 1996-01-16 1997-06-17 Koruga; Djuro L. Method of containing radiation using fullerene molecules
WO1999004826A1 (en) 1997-07-24 1999-02-04 The Australian National University Method for detection of fibrin clots

Also Published As

Publication number Publication date
WO1999004826A1 (en) 1999-02-04
EP1027080A1 (de) 2000-08-16
AU3532197A (en) 1999-02-16
JP3943330B2 (ja) 2007-07-11
CA2297399A1 (en) 1999-02-04
DE69842003D1 (de) 2010-12-30
AU744489B2 (en) 2002-02-28
EP1027080B1 (de) 2010-11-17
US6977068B1 (en) 2005-12-20
WO1999004827A1 (en) 1999-02-04
JP2001510812A (ja) 2001-08-07
CA2297399C (en) 2007-07-03
HK1027041A1 (en) 2001-01-05
EP1027080A4 (de) 2004-07-14
AU8425998A (en) 1999-02-16

Similar Documents

Publication Publication Date Title
ATE488253T1 (de) Verfahren zum nachweis eines fibringerinnsels
DE69816829D1 (de) Verfahren zur erkennung von lecken in rohrleitungen
DE69017636D1 (de) Detektierbarer Gegenstand zur unterirdischen Anwendung und Verfahren zu seiner Lokalisierung.
ATE373822T1 (de) Verfahren zur detektion von markierstoffen in kohlenwasserstoffen und kohlenwasserstoffgemischen
DE69915926D1 (de) Verfahren und Echographiegerät zur Erfassung von Elastizitätsveränderungen
DE69939495D1 (de) Verfahren und system zum testen von computercodes
DE60021216D1 (de) Vorrichtung zur Wiedergabe von Musik, Verfahren zur Taktierungsanalyse und Speichermedium
DE69701314D1 (de) Schlauch und verfahren zur entdeckung von abnutzung
DE59805321D1 (de) Verfahren und anordnung zum erkennen von verteilinformationen
DE69513248D1 (de) Zusammensetzung, Verfahren und System zum Nachweis von Leukocyten, Esterasen oder Proteasen in einer Testprobe
ATE225039T1 (de) Volumenunabhängiger diagnostischer testträger und verfahren zur bestimmung von analyten mit dessen hilfe
ATE225937T1 (de) Diagnostischer testträger mit mehrschichtigem testfeld und verfahren zur bestimmung von analyten mit dessen hilfe
DE69710523D1 (de) Verfahren und Vorrichtung zum Detektieren von Eisenbahnaktivität
DE69826583D1 (de) Vorrichtung und Verfahren zum Erreichen von klinischen wichtigen Analytverhältnissen
DE69534301D1 (de) Kulturmedium und vorrichtung zum nachweis und zur quantifizierung von enterobakteriaceae
DE69520004D1 (de) Verfahren zum feststellen und/oder zum identifizieren von mikrobenkolonien
DE69802831D1 (de) Dynamisches heuristisches verfahren zur erkennung von computerviren
DE69804251D1 (de) Verfahren und vorrichtung zum zementieren von futterrohren in bohrlöchern
DE69709087D1 (de) Verfahren zum nachweis und zur identifizierung von mikroorganismen
DE69821121D1 (de) Verfahren und anordnung zur blutdruckmessung
DE60023779D1 (de) Vorrichtung und Verfahren zur Überblendungsdetektion und Überblendungsinformationscodierung
DE69203640D1 (de) Unsichtbare Kennzeichen für Petroleum, Verfahren zur Markierung und Verfahren zum Nachweisen.
DE69834493D1 (de) Verfahren und gerät zum nachweis und zur zählung von mikroorganismen
DE69918123D1 (de) Verfahren und reagentiensatz zur erkennung von protein-protein wechselwirkungen
DE59813579D1 (de) Verfahren und Diagnosemittel zum Nachweis von Hämostasestörungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties